No Detail Found!

An Observational Study for the Management of Tuberculosis at the Public Hospital of Lahore, Pakistan

Author(s)
Anam Arshad Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.
Rimsha Abaidullah Department of Zoology, Government College University, Lahore, Punjab, Pakistan.
Maria Naz Bakhtiari Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.
Dur E Nayab Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.
Muhammad Zahoor Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.
Abstract
To determine the frequency of iron deficiency anemia (IDA) in children who present with clinical pallor The study was conducted at a tertiary care hospital, Hayatabad Medical Complex, between August 2018 and July 2022. We utilized laboratory information and took blood samples of 5ml to check for hemoglobin and ferritin levels. The criteria for IDA diagnosis were the presence of low hemoglobin levels (<11gm/dl) and low ferritin levels (<30ng/ml). The data were analyzed using SPSS version 26. The study contained 492 children between the ages of 1 year to 15 years. The total number of anemic was 467 (94.9%) and Iron Deficiency Anemia was found to be present in 28.8% of the patients. Our study concludes that the frequency of iron deficiency is high in children presenting with pallor. Initiatives like National programs incorporating short-term measures like iron supplements and long-term ones like fortifying wheat flour could decrease the burden of IDA.
Publication Details
Page(s) 1-17
Published Journal: Global Pharmaceutical Sciences Review, Volume: 8, Issue: 3, Year: 2023

Request the full text from PASTIC

Keywords
Children, Prevalence, Pallor, Children, iron deficiency anemia, Prevalence
References
Programme G. T. .2011 .. int/publications/i/item/9789 241564380, : .
Lung Association American .2012 .. Accessed February 9, : .
Tavitian S. M.,Spalek V. H.,Bailey R. P. .2003 .A pharmacist-managed clinic for treatment of latent tuberculosis infection in health care workers. American Journal of Health-system Pharmacy, 60(18) : 1856-1861.
Troy D. B.,Beringer P. .2006 .. Remington: The Science and Practice of Pharmacy. Lippincott Williams & Wilkins., : .
Dye C. .2006 .Global epidemiology of tuberculosis. The Lancet, 367(9514) : 938-940.
Programme G. T. .2011 .. int/publications/i/item/9789 241564380, 1 : .
. .. php?article_id=2 34, : .
Bennett GL,Dolin JE,R JE .2010 .Principles and practice of infectious diseases. , : 3129-3164.
Corbett EL,Marston B,Churchyard CJ .2012 .Risk of transmission www. Accessed March 9, : .
Mazurek G. H.,Jereb J. A.,Vernon A.,Lobue P. A.,Goldberg S.,Castro K. G.,States K. G. .2010 .Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection. nlm.nih.gov/20577159, 59 : 1-25.
Ena J.,Valls V. .2005 .Short-Course Therapy with Rifampin plus Isoniazid, Compared with Standard Therapy with Isoniazid, for Latent Tuberculosis Infection: A Meta-analysis. Clinical Infectious Diseases/Clinical Infectious Diseases (Online, 40(5) : 670-676.
Jereb J. A.,Goldberg S.,Powell K. M.,Villarino M. E.,LoBue P. .2011 .Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection. Recommendations for Use of an IsoniazidRifapentine Regimen With Direct Observation to Treat Latent Mycobacterium Tuberculosis Infection. , : .
Horne R.,Barber N.,Weinman J.,Ra E.,Cribb M.,A. M. .2006 .-delivery-andorganisation-rd-programme-concordanceadherence-and-compliance-in-medicinetaking(5ed745f3-a769-47bd-a54b09f1c8768e8a)/export. , : .
Cramer J. A.,Roy A.,Burrell A.,Fairchild C.,Fuldeore M.,Ollendorf D. A.,Wong P. .2007 .Medication Compliance and Persistence: Terminology and Definitions. , 00213(1) : 4733-47.
Cuneo W. D.,Snider D. E. .1989 .Enhancing Patient Compliance with Tuberculosis Therapy. Clinics in Chest Medicine, 5231(21) : 00640-7.
WHO .2002 .An expanded DOTS framework for effective tuberculosis control. nlm.nih.gov/12019913, 6(5) : 378-388.
Last J. M.,Kozakiewicz J. .2009 .Development of a pharmacist-managed latent tuberculosis clinic. American Journal of Health-system Pharmacy, 66(17) : 1522-1523.
Clark P. M.,Karagöz T.,Apikoğlu-Rabuş Ş.,İzzettin F. .2007 .Effect of pharmacist-led patient education on adherence to tuberculosis treatment. American Journal of Health-system Pharmacy, 64(5) : 497-505.
FDC containing Rifampicin 150mg,Isoniazid 75mg,Pyrazinamide 400mg . .. Ethambutol 275mg, : .
. .(RHZE) for 2 months according to body weight bands. , : .
FDC containing Rifampicin 150mg,Isoniazid 75mg . .. , : .
Ethambutol 275mg . .. , : .
. .IInjStreptomycin (500-750 mg) (RRHZES for 2 months. , : .
. .EEthambutol(RRHZE for 1month. , : .
. .. , : .
. .100mg/ml. , : .
. .. , : .
. .. , : .
. .. , : .
. .150mg/ml 4mg. , : .
. .10mg/ml 1g. , : .
. .. , : .
. .2 tbs b. , : .
0

Citations

0

Downloads

48

Views